TIBER CREEK GROUP
TIBER CREEK GROUP filed a Q3 report for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) on October 19, 2026, reporting $60,000 in lobbying income.
Lobbying for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Government relations.
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to 340B Drug Pricing Program; General intellectual property issues; Issues related to pharmacy benefit managers; Issues related to Most Favored Nation (MFN) policy.
Issues related to tariff policy and supply chain policy.